Assessment of Retinal Microcirculation in Patients With Type 1 Diabetes Mellitus
1 other identifier
observational
100
1 country
1
Brief Summary
Type 1 diabetes mellitus (T1DM) is associated with an increased lifetime risk of developing diabetic retinopathy, a leading cause of visual impairment among working-age adults worldwide. Retinal assessment plays a pivotal role in the management of patients with T1DM, as the retina provides a unique, non-invasive window into the body's microvascular circulation. Early detection of retinal abnormalities is essential because structural and microvascular changes may develop years before the onset of vision-threatening diabetic retinopathy or visual symptoms. Contemporary retinal imaging techniques, enable the quantitative evaluation of retinal microvasculature allowing the identification of subclinical retinal damage.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2025
CompletedFirst Submitted
Initial submission to the registry
July 6, 2026
CompletedFirst Posted
Study publicly available on registry
July 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 30, 2026
July 15, 2026
July 1, 2026
1.2 years
July 6, 2026
July 12, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Quantitative assessment of retinal vessel density measured by optical coherence tomography angiography (OCTA).
Vessel density will be assessed at baseline using OCTA. This is a cross-sectional study; no follow-up assessments will be performed. Participants will be evaluated at a single study visit and classified according to the stage of diabetic retinopathy.
Study Arms (1)
Patients with Type 1 diabetes mellitus with and without clinically diagnosed diabetic retinopathy
Interventions
A non-invasive retinal imaging technique that provides high-resolution visualization and quantitative assessment of the retinal and choroidal microvasculature, including vessel density and the foveal avascular zone, without the use of intravenous dye.
Eligibility Criteria
Adults with Type 1 diabetes mellitus, with or without clinically diagnosed diabetic retinopathy, recruited from the 2nd Department Ophthalmology outpatient clinics with and without diabetic retinopathy.
You may qualify if:
- Adults aged 18 years or older.
- Diagnosis of Type 1 diabetes mellitus (T1DM) according to the American Diabetes Association (ADA) criteria.
- Ability and willingness to provide written informed consent.
You may not qualify if:
- Active uveitis or other intraocular inflammatory disease.
- Uncontrolled glaucoma
- High myopia (spherical equivalent refractive error \>5.0 diopters)
- History of ocular trauma.
- History of intraocular surgery within the previous 6 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
2nd Department of Ophthalmology, Attikon University Hospital, National and Kapodistrian University of Athens
Athens, 12462, Greece
Related Publications (1)
Cutruzzola A, Carnevali A, Gatti V, Latella G, Lamonica L, Oliverio F, Borelli M, Parise M, Di Molfetta S, Scorcia V, Irace C, Gnasso A. Continuous Glucose Monitoring-Derived Metrics and Capillary Vessel Density in Subjects with Type 1 Diabetes without Diabetic Retinopathy. J Diabetes Res. 2023 Apr 15;2023:9516059. doi: 10.1155/2023/9516059. eCollection 2023.
PMID: 37096234BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor in Ophthalmology, 2nd Department of Ophthalmology, National and Kapodistrian University of Athens, Athens, Greece
Study Record Dates
First Submitted
July 6, 2026
First Posted
July 15, 2026
Study Start
June 1, 2025
Primary Completion (Estimated)
August 30, 2026
Study Completion (Estimated)
September 30, 2026
Last Updated
July 15, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share